Cardio-oncology Training in the COVID-19 Era.
Curr Treat Options Oncol
; 22(7): 58, 2021 06 07.
Статья
в английский
| MEDLINE | ID: covidwho-1258267
ABSTRACT
OPINION STATEMENT Cardio-oncology is a field dedicated to the prevention, diagnosis, and management of cardiovascular disease in cancer patients before, during, and after cancer therapy. It is an emerging field with limited opportunities for structured education and training. In the year 2021, we cannot define the requirements of cardio-oncology training without acknowledging the impact of the global coronavirus disease 19 (COVID-19) pandemic. While this pandemic poses significant health risks to patients with cancer and cardiovascular disease as well as the providers who care for them, it also allows novel opportunities for the nascent field of cardio-oncology to readily adapt. In this article, we detail how the COVID-19 pandemic has impacted all aspects of cardio-oncology training, how programs and trainees can adapt to these challenges, and how lessons learned from the COVID-19 era can continue to positively impact cardio-oncology training for the foreseeable future.
ключевые слова
Полный текст:
Имеется в наличии
Коллекция:
Международные базы данных
база данных:
MEDLINE
Основная тема:
Cardiovascular Diseases
/
COVID-19
/
Neoplasms
Тип исследования:
Экспериментальные исследования
/
Прогностическое исследование
Темы:
Длинный Ковид
Пределы темы:
Люди
Язык:
английский
Журнал:
Curr Treat Options Oncol
Тематика журнала:
Онкология
Год:
2021
Тип:
Статья
Аффилированная страна:
S11864-021-00855-y
Документы, близкие по теме
MEDLINE
...
LILACS
LIS